Eighth edition staging of thoracic malignancies

Implications for the reporting pathologist

Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Context.-The Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer, in conjunction with the International Mesothelioma Interest Group, the International Thymic Malignancy Interest Group, and the Worldwide Esophageal Cancer Collaboration, developed proposals for the 8th edition of their respective tumor, node, metastasis (TNM) staging classification systems. Objective.-To review these changes and discuss issues for the reporting pathologist. Data Sources.-Proposals were based on international databases of lung (N=94 708), with an external validation using the US National Cancer Database; mesothelioma (N = 3519); thymic epithelial tumors (10 808); and epithelial cancers of the esophagus and esophagogastric junction (N = 22 654). Conclusions.-These proposals have been mostly accepted by the Union for International Cancer Control and the American Joint Committee on Cancer and incorporated into their respective staging manuals (2017). The Union for International Cancer Control recommended implementation beginning in January 2017; however, the American Joint Committee on Cancer has deferred deployment of the eighth TNM until January 1, 2018, to ensure appropriate infrastructure for data collection. This manuscript summarizes the updated staging of thoracic malignancies, specifically highlighting changes from the 7th edition that are relevant to pathologic staging. Histopathologists should become familiar with, and start to incorporate, the 8th edition staging in their daily reporting of thoracic cancers henceforth.

Original languageEnglish
Pages (from-to)645-661
Number of pages17
JournalArchives of Pathology and Laboratory Medicine
Volume142
Issue number5
DOIs
Publication statusPublished - 2018 May 1

Fingerprint

Thorax
Neoplasms
Public Opinion
Mesothelioma
Esophageal Neoplasms
Pathologists
Databases
Neoplasm Metastasis
Esophagogastric Junction
Information Storage and Retrieval
Lung

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees (2018). Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist. Archives of Pathology and Laboratory Medicine, 142(5), 645-661. https://doi.org/10.5858/arpa.2017-0245-RA

Eighth edition staging of thoracic malignancies : Implications for the reporting pathologist. / Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees.

In: Archives of Pathology and Laboratory Medicine, Vol. 142, No. 5, 01.05.2018, p. 645-661.

Research output: Contribution to journalReview article

Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees 2018, 'Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist', Archives of Pathology and Laboratory Medicine, vol. 142, no. 5, pp. 645-661. https://doi.org/10.5858/arpa.2017-0245-RA
Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees. Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist. Archives of Pathology and Laboratory Medicine. 2018 May 1;142(5):645-661. https://doi.org/10.5858/arpa.2017-0245-RA
Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees. / Eighth edition staging of thoracic malignancies : Implications for the reporting pathologist. In: Archives of Pathology and Laboratory Medicine. 2018 ; Vol. 142, No. 5. pp. 645-661.
@article{dfab52d4d35545d3badd8680ca37ee12,
title = "Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist",
abstract = "Context.-The Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer, in conjunction with the International Mesothelioma Interest Group, the International Thymic Malignancy Interest Group, and the Worldwide Esophageal Cancer Collaboration, developed proposals for the 8th edition of their respective tumor, node, metastasis (TNM) staging classification systems. Objective.-To review these changes and discuss issues for the reporting pathologist. Data Sources.-Proposals were based on international databases of lung (N=94 708), with an external validation using the US National Cancer Database; mesothelioma (N = 3519); thymic epithelial tumors (10 808); and epithelial cancers of the esophagus and esophagogastric junction (N = 22 654). Conclusions.-These proposals have been mostly accepted by the Union for International Cancer Control and the American Joint Committee on Cancer and incorporated into their respective staging manuals (2017). The Union for International Cancer Control recommended implementation beginning in January 2017; however, the American Joint Committee on Cancer has deferred deployment of the eighth TNM until January 1, 2018, to ensure appropriate infrastructure for data collection. This manuscript summarizes the updated staging of thoracic malignancies, specifically highlighting changes from the 7th edition that are relevant to pathologic staging. Histopathologists should become familiar with, and start to incorporate, the 8th edition staging in their daily reporting of thoracic cancers henceforth.",
author = "{Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees} and Nicholson, {Andrew G.} and Tsao, {Ming S.} and Travis, {William D.} and Patil, {Deepa T.} and Francoise Galateau-Salle and Mirella Marino and Sanja Dacic and Beasley, {Mary Beth} and Butnor, {Kelly J.} and Yasushi Yatabe and Pass, {Harvey I.} and Rusch, {Valerie W.} and Detterbeck, {Frank C.} and Hisao Asamura and Rice, {Thomas W.} and Ramon Rami-Porta and Peter Goldstraw and David Ball and David Beer and Ricardo Beyruti and Vanessa Bolejack and Kari Chansky and John Crowley and Eberhardt, {Wilfried Ernst Erich} and John Edwards and Dorothy Giroux and Fergus Gleeson and Patti Groome and James Huang and Catherine Kennedy and Jhingook Kim and Kim, {Young Tae} and Laura Kingsbury and Haruhiko Kondo and Mark Krasnik and Kaoru Kubota and Toni Lerut and Gustavo Lyons and Marom, {Edith M.} and {Van Meerbeeck}, Jan and Alan Mitchell and Takashi Nakano and Anna Nowak and Michael Peake and Kenneth Rosenzweig and Enrico Ruffini and Nagahiro Saijo and {Van Schil}, Paul and Sculier, {Jean Paul} and Lynn Shemanski",
year = "2018",
month = "5",
day = "1",
doi = "10.5858/arpa.2017-0245-RA",
language = "English",
volume = "142",
pages = "645--661",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "5",

}

TY - JOUR

T1 - Eighth edition staging of thoracic malignancies

T2 - Implications for the reporting pathologist

AU - Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees

AU - Nicholson, Andrew G.

AU - Tsao, Ming S.

AU - Travis, William D.

AU - Patil, Deepa T.

AU - Galateau-Salle, Francoise

AU - Marino, Mirella

AU - Dacic, Sanja

AU - Beasley, Mary Beth

AU - Butnor, Kelly J.

AU - Yatabe, Yasushi

AU - Pass, Harvey I.

AU - Rusch, Valerie W.

AU - Detterbeck, Frank C.

AU - Asamura, Hisao

AU - Rice, Thomas W.

AU - Rami-Porta, Ramon

AU - Goldstraw, Peter

AU - Ball, David

AU - Beer, David

AU - Beyruti, Ricardo

AU - Bolejack, Vanessa

AU - Chansky, Kari

AU - Crowley, John

AU - Eberhardt, Wilfried Ernst Erich

AU - Edwards, John

AU - Giroux, Dorothy

AU - Gleeson, Fergus

AU - Groome, Patti

AU - Huang, James

AU - Kennedy, Catherine

AU - Kim, Jhingook

AU - Kim, Young Tae

AU - Kingsbury, Laura

AU - Kondo, Haruhiko

AU - Krasnik, Mark

AU - Kubota, Kaoru

AU - Lerut, Toni

AU - Lyons, Gustavo

AU - Marom, Edith M.

AU - Van Meerbeeck, Jan

AU - Mitchell, Alan

AU - Nakano, Takashi

AU - Nowak, Anna

AU - Peake, Michael

AU - Rosenzweig, Kenneth

AU - Ruffini, Enrico

AU - Saijo, Nagahiro

AU - Van Schil, Paul

AU - Sculier, Jean Paul

AU - Shemanski, Lynn

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Context.-The Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer, in conjunction with the International Mesothelioma Interest Group, the International Thymic Malignancy Interest Group, and the Worldwide Esophageal Cancer Collaboration, developed proposals for the 8th edition of their respective tumor, node, metastasis (TNM) staging classification systems. Objective.-To review these changes and discuss issues for the reporting pathologist. Data Sources.-Proposals were based on international databases of lung (N=94 708), with an external validation using the US National Cancer Database; mesothelioma (N = 3519); thymic epithelial tumors (10 808); and epithelial cancers of the esophagus and esophagogastric junction (N = 22 654). Conclusions.-These proposals have been mostly accepted by the Union for International Cancer Control and the American Joint Committee on Cancer and incorporated into their respective staging manuals (2017). The Union for International Cancer Control recommended implementation beginning in January 2017; however, the American Joint Committee on Cancer has deferred deployment of the eighth TNM until January 1, 2018, to ensure appropriate infrastructure for data collection. This manuscript summarizes the updated staging of thoracic malignancies, specifically highlighting changes from the 7th edition that are relevant to pathologic staging. Histopathologists should become familiar with, and start to incorporate, the 8th edition staging in their daily reporting of thoracic cancers henceforth.

AB - Context.-The Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer, in conjunction with the International Mesothelioma Interest Group, the International Thymic Malignancy Interest Group, and the Worldwide Esophageal Cancer Collaboration, developed proposals for the 8th edition of their respective tumor, node, metastasis (TNM) staging classification systems. Objective.-To review these changes and discuss issues for the reporting pathologist. Data Sources.-Proposals were based on international databases of lung (N=94 708), with an external validation using the US National Cancer Database; mesothelioma (N = 3519); thymic epithelial tumors (10 808); and epithelial cancers of the esophagus and esophagogastric junction (N = 22 654). Conclusions.-These proposals have been mostly accepted by the Union for International Cancer Control and the American Joint Committee on Cancer and incorporated into their respective staging manuals (2017). The Union for International Cancer Control recommended implementation beginning in January 2017; however, the American Joint Committee on Cancer has deferred deployment of the eighth TNM until January 1, 2018, to ensure appropriate infrastructure for data collection. This manuscript summarizes the updated staging of thoracic malignancies, specifically highlighting changes from the 7th edition that are relevant to pathologic staging. Histopathologists should become familiar with, and start to incorporate, the 8th edition staging in their daily reporting of thoracic cancers henceforth.

UR - http://www.scopus.com/inward/record.url?scp=85046649682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046649682&partnerID=8YFLogxK

U2 - 10.5858/arpa.2017-0245-RA

DO - 10.5858/arpa.2017-0245-RA

M3 - Review article

VL - 142

SP - 645

EP - 661

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 5

ER -